Trials / Completed
CompletedNCT00092755
An Investigational Drug in Patients With Osteoarthritis (0663-073)
A 12-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Ibuprofen 2400 mg in Patients With Osteoarthritis (Study 2)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 548 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study was conducted to assess the safety and tolerability of an investigational drug and to evaluate its effectiveness in the treatment of osteoarthritis of the hip or knee in both men and women.
Detailed description
The duration of treatment is 12 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0663, etoricoxib | |
| DRUG | Comparators: ibuprofen and placebo |
Timeline
- Start date
- 2003-04-09
- Primary completion
- 2003-11-13
- Completion
- 2003-11-13
- First posted
- 2004-09-28
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00092755. Inclusion in this directory is not an endorsement.